240 related articles for article (PubMed ID: 1373333)
1. Effect of inflammatory cytokines on hypoxia-induced erythropoietin production.
Faquin WC; Schneider TJ; Goldberg MA
Blood; 1992 Apr; 79(8):1987-94. PubMed ID: 1373333
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of erythropoietin production in vitro by human interferon gamma.
Vannucchi AM; Grossi A; Rafanelli D; Statello M; Cinotti S; Rossi-Ferrini P
Br J Haematol; 1994 May; 87(1):18-23. PubMed ID: 7947242
[TBL] [Abstract][Full Text] [Related]
3. Distinct signaling pathways mediate phorbol-ester-induced and cytokine-induced inhibition of erythropoietin gene expression.
Fandrey J; Huwiler A; Frede S; Pfeilschifter J; Jelkmann W
Eur J Biochem; 1994 Dec; 226(2):335-40. PubMed ID: 7528138
[TBL] [Abstract][Full Text] [Related]
4. [Relationship between tumor necrosis factor alpha, interleukin-6 and erythropoietin in children's with chronic anemia and influence of recombinant human tumor necrosis factor alpha on erythropoietin gene expression].
Zhai XW; Wu Y; Gu XF; Lu FJ
Zhonghua Er Ke Za Zhi; 2004 Jan; 42(1):62-5. PubMed ID: 14990112
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of erythropoietin gene expression signaling involves the transcription factors GATA-2 and NF-kappaB.
La Ferla K; Reimann C; Jelkmann W; Hellwig-Bürgel T
FASEB J; 2002 Nov; 16(13):1811-3. PubMed ID: 12223449
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of erythropoietin production by cytokines. Implications for the anemia involved in inflammatory states.
Jelkmann WE; Fandrey J; Frede S; Pagel H
Ann N Y Acad Sci; 1994 Apr; 718():300-9; discussion 309-11. PubMed ID: 8185237
[TBL] [Abstract][Full Text] [Related]
7. Interleukin-1 and tumor necrosis factor-alpha inhibit erythropoietin production in vitro.
Fandrey J; Jelkmann WE
Ann N Y Acad Sci; 1991; 628():250-5. PubMed ID: 1712553
[TBL] [Abstract][Full Text] [Related]
8. Cytokine interactions promote synergistic fibronectin accumulation by mesangial cells.
Pawluczyk IZ; Harris KP
Kidney Int; 1998 Jul; 54(1):62-70. PubMed ID: 9648064
[TBL] [Abstract][Full Text] [Related]
9. Modulators of protein kinase C inhibit hypoxia-induced erythropoietin production.
Faquin WC; Schneider TJ; Goldberg MA
Exp Hematol; 1993 Mar; 21(3):420-6. PubMed ID: 7679999
[TBL] [Abstract][Full Text] [Related]
10. Ability of flt3 ligand to stimulate the in vitro growth of primitive murine hematopoietic progenitors is potently and directly inhibited by transforming growth factor-beta and tumor necrosis factor-alpha.
Jacobsen SE; Veiby OP; Myklebust J; Okkenhaug C; Lyman SD
Blood; 1996 Jun; 87(12):5016-26. PubMed ID: 8652814
[TBL] [Abstract][Full Text] [Related]
11. Erythropoietin gene expression is suppressed after lipopolysaccharide or interleukin-1 beta injections in rats.
Frede S; Fandrey J; Pagel H; Hellwig T; Jelkmann W
Am J Physiol; 1997 Sep; 273(3 Pt 2):R1067-71. PubMed ID: 9321887
[TBL] [Abstract][Full Text] [Related]
12. Differential effects of the hematopoietic inhibitors MIP-1 alpha, TGF-beta, and TNF-alpha on cytokine-induced proliferation of subpopulations of CD34+ cells purified from cord blood and fetal liver.
Mayani H; Little MT; Dragowska W; Thornbury G; Lansdorp PM
Exp Hematol; 1995 May; 23(5):422-7. PubMed ID: 7536684
[TBL] [Abstract][Full Text] [Related]
13. A GATA-specific inhibitor (K-7174) rescues anemia induced by IL-1beta, TNF-alpha, or L-NMMA.
Imagawa S; Nakano Y; Obara N; Suzuki N; Doi T; Kodama T; Nagasawa T; Yamamoto M
FASEB J; 2003 Sep; 17(12):1742-4. PubMed ID: 12958195
[TBL] [Abstract][Full Text] [Related]
14. Regulation of rat pulmonary artery endothelial cell transforming growth factor-beta production by IL-1 beta and tumor necrosis factor-alpha.
Phan SH; Gharaee-Kermani M; McGarry B; Kunkel SL; Wolber FW
J Immunol; 1992 Jul; 149(1):103-6. PubMed ID: 1376744
[TBL] [Abstract][Full Text] [Related]
15. Predominant role of tumor necrosis factor-alpha in human monocyte IL-10 synthesis.
Wanidworanun C; Strober W
J Immunol; 1993 Dec; 151(12):6853-61. PubMed ID: 8258695
[TBL] [Abstract][Full Text] [Related]
16. Interleukin 1, interleukin 6, tumor necrosis factor, and transforming growth factor beta increase cell resistance to tumor necrosis factor cytotoxicity by growth arrest in the G1 phase of the cell cycle.
Belizario JE; Dinarello CA
Cancer Res; 1991 May; 51(9):2379-85. PubMed ID: 2015601
[TBL] [Abstract][Full Text] [Related]
17. Modulation of urokinase-type plasminogen activator gene expression by inflammatory cytokines in human pre-B lymphoma cell line RC-K8.
Niiya K; Shinbo M; Ozawa T; Hayakawa Y; Sakuragawa N
Thromb Haemost; 1995 Dec; 74(6):1511-5. PubMed ID: 8772229
[TBL] [Abstract][Full Text] [Related]
18. Contrasting mechanisms for suppression of macrophage cytokine release by transforming growth factor-beta and interleukin-10.
Bogdan C; Paik J; Vodovotz Y; Nathan C
J Biol Chem; 1992 Nov; 267(32):23301-8. PubMed ID: 1429677
[TBL] [Abstract][Full Text] [Related]
19. Nitric oxide synthesis in cardiac myocytes and fibroblasts by inflammatory cytokines.
Shindo T; Ikeda U; Ohkawa F; Kawahara Y; Yokoyama M; Shimada K
Cardiovasc Res; 1995 Jun; 29(6):813-9. PubMed ID: 7544689
[TBL] [Abstract][Full Text] [Related]
20. TGF-beta 1, IL-10 and IL-4 differentially modulate the cytokine-induced expression of IL-6 and IL-8 in human endothelial cells.
Chen CC; Manning AM
Cytokine; 1996 Jan; 8(1):58-65. PubMed ID: 8742067
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
